本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

43.63
-0.9900-2.22%
盤後43.630.00000.00%19:30 EDT
成交量:296.96萬
成交額:1.30億
市值:47.38億
市盈率:-23.58
高:45.02
開:44.69
低:42.61
收:44.62
52周最高:48.40
52周最低:13.85
股本:1.09億
流通股本:8,817.09萬
量比:2.81
換手率:3.37%
股息:- -
股息率:- -
每股收益(TTM):-1.8502
每股收益(LYR):-1.6302
淨資產收益率:-38.03%
總資產收益率:-25.03%
市淨率:10.57
市盈率(LYR):-26.76

資料載入中...

2023/03/06

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/23

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/03

重要事件披露

8-K - Current report
2022/09/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

重要事件披露

8-K - Current report
2022/09/13

重要事件披露

8-K - Current report
2022/08/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]